Drug Information Association Logo

The Harmonization of Risk Management in the EU and the US: The Example of Vandetanib

Time

Mon, Jun 16 7:45AM
M 10

Title

The Harmonization of Risk Management in the EU and the US: The Example of Vandetanib

Abstract Summary

Conduct an analysis of the important identified risks with additional pharmacovigilance activities in the EU RMP and a comparison with the information contained in the US REMS for vandetanib. The required information was accessed via the EMA/FDA/MAH websites available to consumers.

Poster Presenter

Agata Aleksandra Lazowska
PhD Student,
University of Bonn
Germany